EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE - REPLY

被引:0
|
作者
RAY, WA [1 ]
GRIFFIN, MR [1 ]
AVORN, J [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 330卷 / 19期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1394 / 1395
页数:2
相关论文
共 50 条
  • [1] EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE
    RAY, WA
    GRIFFIN, MR
    AVORN, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27): : 2029 - 2032
  • [2] Clinical pharmacology:: knowledge acquired on drugs after their approval
    Bramlage, P.
    Boecking, W.
    Kirch, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (25-26) : 1485 - 1487
  • [3] Evidence Required for Drugs Granted Accelerated Approval Reply
    Naci, Huseyin
    Kesselheim, Aaron S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (24): : 2493 - 2494
  • [4] Balancing Accelerated Approval for Drugs With Accelerated Withdrawal Reply
    Kim, Chul
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2016, 176 (04) : 567 - 567
  • [5] Approval of drugs and chemicals for use by the aquaculture industry
    Schnick, RA
    VETERINARY AND HUMAN TOXICOLOGY, 1998, 40 : 9 - 17
  • [6] Approval of Drugs With Unmet Trial End Points-In Reply
    Johnston, James L.
    Ross, Joseph S.
    Ramachandran, Reshma
    JAMA INTERNAL MEDICINE, 2023, 183 (08) : 889 - 890
  • [7] EVALUATING DRUGS FOR USE IN CHILDREN
    THOMPSON, RC
    FDA CONSUMER, 1975, 9 (02) : 14 - 17
  • [8] Verifying Clinical Benefit of New Anticancer Drugs After Regulatory Approval Based on Exploratory Studies
    Ito, Akira
    Narukawa, Mamoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025,
  • [9] Clinical Approval Success Rates for Investigational Cancer Drugs
    DiMasi, J. A.
    Reichert, J. M.
    Feldman, L.
    Malins, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 329 - 335
  • [10] EVALUATING DRUGS IN RHEUMATOID-ARTHRITIS - REPLY
    SCOTT, DL
    ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (09) : 791 - 791